ALBUQUERQUE, N.M. – OSO BioPharmaceuticals Manufacturing, LLC has appointed Rick Lapointe as Vice President of Technology and Acquisitions.
In his new capacity, Lapointe will work closely with the senior leadership team to increase OsoBio’s capabilities, identify new business opportunities and develop strategies to meet its long-term business objectives.
A seasoned business-development and operations professional with more than 25 years of experience working with biotechnology and pharmaceutical companies, Lapointe joins OsoBio at an important time in the growth of its business, said Milton Boyer, Vice President of Business Development and Sales.
“Rick’s distinguished track record within our industry and his extensive experience will be a great resource to us as a company,” Boyer said. “We’re pleased to welcome Rick to the OsoBio team.”
Prior to joining OsoBio, Lapointe served as Head of Contract Manufacturing at Hollister Stier Laboratories and as Director of Manufacturing at Bayer Corp.
OSO BioPharmaceuticals Manufacturing, LLC is a contract manufacturing organization (CMO) focusing on biologic and pharmaceutical injectables. Headquartered in Albuquerque, N.M., OsoBio specializes in products requiring complex handling, including highly potent compounds.
Responsiveness, attention to detail and clear communication are the hallmarks of our client care. OsoBio surpasses quality-assurance expectations within our industry. Our employees are industry veterans who provide innovative solutions to our clients’ most difficult projects. To learn more about our company and the value we offer clients, visit www.OsoBio.com.